APA
Münzker J., Hofer D., Trummer C., Ulbing M., Harger A., Pieber T., Owen L., Keevil B., Brabant G., Lerchbaum E. & Obermayer-Pietsch B. (20150414). Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome. : The Journal of clinical endocrinology and metabolism.
Chicago
Münzker J, Hofer D, Trummer C, Ulbing M, Harger A, Pieber T, Owen L, Keevil B, Brabant G, Lerchbaum E and Obermayer-Pietsch B. 20150414. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome. : The Journal of clinical endocrinology and metabolism.
Harvard
Münzker J., Hofer D., Trummer C., Ulbing M., Harger A., Pieber T., Owen L., Keevil B., Brabant G., Lerchbaum E. and Obermayer-Pietsch B. (20150414). Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome. : The Journal of clinical endocrinology and metabolism.
MLA
Münzker J, Hofer D, Trummer C, Ulbing M, Harger A, Pieber T, Owen L, Keevil B, Brabant G, Lerchbaum E and Obermayer-Pietsch B. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome. : The Journal of clinical endocrinology and metabolism. 20150414.